Submitted on March 9, 2020 - USP Comment Letter to FDA on FDA/FTC Workshop on a Competitive Marketplace for Biosimilars. Docket No. FDA-2019-N-6050.
USP-comments-to-FDA-FTC-on-biosimilars.pdf
(117.48 KB)
Submitted on March 9, 2020 - USP Comment Letter to FDA on FDA/FTC Workshop on a Competitive Marketplace for Biosimilars. Docket No. FDA-2019-N-6050.